0
Original Contributions |

Archetypal and New Families With Alexander Disease and Novel Mutations in GFAP

Albee Messing, VMD, PhD; Rong Li, PhD; Sakkubai Naidu, MD; J. Paul Taylor, MD, PhD; Lital Silverman, BS; Daniel Flint, BA; Marjo S. van der Knaap, MD, PhD; Michael Brenner, PhD
Arch Neurol. 2012;69(2):208-214. doi:10.1001/archneurol.2011.1181.
Text Size: A A A
Published online

Objective  To describe genetic analyses of the 2 most thoroughly studied, historically seminal multigenerational families with Alexander disease described prior to the identification of GFAP as the related gene, as well as 1 newly discovered family.

Design  Clinical histories were obtained and DNA was analyzed from blood, cheek epithelial cells, or fixed paraffin-embedded surgical samples.

Subjects  Affected and unaffected adult members of 3 families and affected children were included.

Main Outcome Measures  Mutations in GFAP and behavior of mutant protein in cellular transfection assays.

Results  Family A contains 4 siblings in whom we found a novel p.Ser247Pro mutation that was paternally inherited. The phenotypes of these siblings include 1 unaffected adult, 1 individual with juvenile-onset disease, and 2 individuals with adult-onset disease. Family B spans 4 generations, including the first described patient with adult-onset disease originally reported in 1968. Analysis of members of the later generations revealed a novel p.Asp417Ala mutation. Family C contains 3 generations. We detected a novel p.Gln426Leu mutation that, to our knowledge, is the farthest C-terminal mutation known.

Conclusions  These families display clear evidence of variable phenotypes but do not support recessive inheritance. While germline mosaicism cannot be excluded for 1 family (A), we propose that for genetic counseling purposes the risk of germline mosaicism should be described as less than 1%.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Place holder to copy figure label and caption
Grahic Jump Location

Figure 1. Pedigrees of 3 families with Alexander disease. Numbers below each symbol indicate the age at onset (o) and the age at most recent report or death (d). Genotypes, where available, are indicated by a plus or minus sign above a symbol. Affected individuals are indicated by filled symbols, and individuals with relevant clinical signs and considered probably affected are indicated by gray shading. A, Siblings and parents of the 2 patients initially reported by Duckett et al3 (II.c and II.d in this diagram). Birth order has been scrambled to protect confidentiality. B, Four-generation family related to the patients with adult-onset disease originally reported by Seil et al2 (III.F in this diagram) and Schwankhaus et al8 (IV.B, IV.D, and IV.F in this diagram), continuing the nomenclature used by Schwankhaus et al.8 Generations I and II of this original pedigree contained no informative individuals and are not illustrated. C, Two-generation family (not previously described).

Place holder to copy figure label and caption
Grahic Jump Location

Figure 2. Magnetic resonance images of 2 affected members of family A. A, Sagittal T1-weighted image of patient II.c, at age 46 years, showing a lesion in the pons (dark arrow) and severe atrophy of the medulla oblongata (white arrow).The cerebellar white matter (arrowhead) has a low signal, which is abnormal. B, Sagittal T1-weighted image after contrast of patient II.d, at age 15 years, showing an enhancing lesion in the dorsal brain stem. Previous magnetic resonance images reported by Duckett et al3 for this patient indicated a space-occupying mass in the left cerebellar hemisphere and signal changes in the deep cerebellar white matter. Patients II.d and II.f had no significant changes in cerebral white matter.

Place holder to copy figure label and caption
Grahic Jump Location

Figure 3. Magnetic resonance images from patient VI.A of family B at age 8.5 years. A, Sagittal T1-weighted image after contrast reveals an enhancing tumorlike lesion in the dorsal part of the medulla and lower pons. B, Axial fluid-attenuated inversion recovery image shows the mass lesion in the medulla in the left posterior part. C, Axial fluid-attenuated inversion recovery image shows signal abnormalities in the frontal white matter (white arrows), head of the caudate nucleus (black arrow), and putamen (arrowhead).

Place holder to copy figure label and caption
Grahic Jump Location

Figure 4. Effects of pSer247Pro, p.Asp417Ala, and p.Gln426Leu mutations on filament assembly in transfected SW13vim cells. Staining with 4',6-diamidino-2-phenylindole in parts A, C, and D indicates the position of nuclei. A, Transfection with the wild-type (wt) GFAP expression vector. A normal filamentous assembly pattern is seen, consisting of a fine network with or without diffuse background in about 90% of cells. B-D, Transfection with vectors expressing p.Ser247Pro (B), p.Asp417Ala (C), or p.GlnP.GLN426LEUeu (D), each producing ringlike filaments on a background of diffuse staining. The inset in panel B shows results for cotransfection with an equal amount of wt GFAP expression vector, demonstrating the dominant effect of the mutation.

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 1

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs